Compare Dr. Reddys with J.B.Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. REDDYS LAB vs J.B.CHEMICALS - Comparison Results

DR. REDDYS LAB     Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the pharmaceutical value chain - basic research, finished dosages, generics, bulk actives, and biotechnology. The company's business is mainly organized into Global g... More

J.B.CHEMICALS 
   Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. REDDYS LAB J.B.CHEMICALS DR. REDDYS LAB/
J.B.CHEMICALS
 
P/E (TTM) x 38.0 38.5 98.7% View Chart
P/BV x 5.2 7.2 72.6% View Chart
Dividend Yield % 0.5 0.2 310.8%  

Financials

 DR. REDDYS LAB   J.B.CHEMICALS
EQUITY SHARE DATA
    DR. REDDYS LAB
Mar-20
J.B.CHEMICALS
Mar-18
DR. REDDYS LAB/
J.B.CHEMICALS
5-Yr Chart
Click to enlarge
High Rs3,363363 926.2%   
Low Rs2,352255 922.4%   
Sales per share (Unadj.) Rs1,054.2169.1 623.2%  
Earnings per share (Unadj.) Rs121.916.6 734.5%  
Cash flow per share (Unadj.) Rs190.223.4 812.3%  
Dividends per share (Unadj.) Rs25.002.00 1,250.0%  
Dividend yield (eoy) %0.90.6 135.2%  
Book value per share (Unadj.) Rs938.7172.5 544.2%  
Shares outstanding (eoy) m166.1783.57 198.8%   
Bonus/Rights/Conversions ESOPBB-  
Price / Sales ratio x2.71.8 148.4%   
Avg P/E ratio x23.418.6 125.9%  
P/CF ratio (eoy) x15.013.2 113.8%  
Price / Book Value ratio x3.01.8 169.9%  
Dividend payout %20.512.0 170.2%   
Avg Mkt Cap Rs m474,83125,827 1,838.5%   
No. of employees `00021.73.8 574.0%   
Total wages/salary Rs m33,8022,511 1,346.2%   
Avg. sales/employee Rs Th8,091.03,747.4 215.9%   
Avg. wages/employee Rs Th1,561.3665.7 234.5%   
Avg. net profit/employee Rs Th935.8367.8 254.5%   
INCOME DATA
Net Sales Rs m175,17014,135 1,239.3%  
Other income Rs m6,206366 1,696.6%   
Total revenues Rs m181,37614,501 1,250.8%   
Gross profit Rs m24,4212,178 1,121.1%  
Depreciation Rs m11,348570 1,991.9%   
Interest Rs m98335 2,816.6%   
Profit before tax Rs m18,2961,940 943.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m5610-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1,403552 -254.0%   
Profit after tax Rs m20,2601,387 1,460.5%  
Gross profit margin %13.915.4 90.5%  
Effective tax rate %-7.728.5 -26.9%   
Net profit margin %11.69.8 117.9%  
BALANCE SHEET DATA
Current assets Rs m125,99110,470 1,203.4%   
Current liabilities Rs m72,1412,749 2,624.3%   
Net working cap to sales %30.754.6 56.3%  
Current ratio x1.73.8 45.9%  
Inventory Days Days7355 132.4%  
Debtors Days Days10578 134.9%  
Net fixed assets Rs m83,8545,811 1,443.0%   
Share capital Rs m831167 497.3%   
"Free" reserves Rs m155,15714,248 1,088.9%   
Net worth Rs m155,98814,416 1,082.1%   
Long term debt Rs m1,3040-   
Total assets Rs m232,25317,649 1,316.0%  
Interest coverage x19.656.6 34.7%   
Debt to equity ratio x00-  
Sales to assets ratio x0.80.8 94.2%   
Return on assets %9.18.1 113.5%  
Return on equity %13.09.6 135.0%  
Return on capital %12.613.7 92.1%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m84,1936,164 1,365.9%   
Fx outflow Rs m39,6161,334 2,968.8%   
Net fx Rs m44,5774,829 923.0%   
CASH FLOW
From Operations Rs m29,8411,231 2,425.1%  
From Investments Rs m-4,923-208 2,365.7%  
From Financial Activity Rs m-25,159-595 4,227.0%  
Net Cashflow Rs m-266427 -62.3%  

Share Holding

Indian Promoters % 25.5 55.4 46.0%  
Foreign collaborators % 0.0 0.3 -  
Indian inst/Mut Fund % 5.4 3.4 159.3%  
FIIs % 35.3 3.9 905.1%  
ADR/GDR % 18.5 0.0 -  
Free float % 15.3 37.0 41.4%  
Shareholders   75,885 30,437 249.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. REDDYS LAB With:   JUBILANT PHARMOVA   PANACEA BIOTECH  WOCKHARDT  ABBOTT INDIA  FRESENIUS KABI ONCO.  

Compare DR. REDDYS LAB With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Flat; Wipro & Hindalco Industries Among Top Nifty Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Related Views on News

J.B.CHEMICALS Announces Quarterly Results (3QFY20); Net Profit Up 34.1% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, J.B.CHEMICALS has posted a net profit of Rs 622 m (up 34.1% YoY). Sales on the other hand came in at Rs 4 bn (up 9.3% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

J.B.CHEMICALS Announces Quarterly Results (4QFY19); Net Profit Up 91.2% (Quarterly Result Update)

May 24, 2019 | Updated on May 24, 2019

For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

J.B.CHEMICALS Announces Quarterly Results (3QFY20); Net Profit Up 34.1% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, J.B.CHEMICALS has posted a net profit of Rs 622 m (up 34.1% YoY). Sales on the other hand came in at Rs 4 bn (up 9.3% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

J.B.CHEMICALS Announces Quarterly Results (4QFY19); Net Profit Up 91.2% (Quarterly Result Update)

May 24, 2019 | Updated on May 24, 2019

For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games?(The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

4 Stocks to Make Your Portfolio Immune to the Second Covid Wave(Profit Hunter)

Apr 6, 2021

Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.

An India Revival Stock I'm Bullish On...(Profit Hunter)

Apr 9, 2021

This could take India to the position of 3rd largest economy.

Why Did the Market Crash on Monday?(Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

A Unique Sector for Short-Term Profits(Fast Profits Daily)

Apr 12, 2021

This ignored sector could deliver big short-term profits.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

DR. REDDYS LAB SHARE PRICE


Apr 16, 2021 (Close)

TRACK DR. REDDYS LAB

  • Track your investment in DR. REDDYS LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

DR. REDDYS LAB 8-QTR ANALYSIS

COMPARE DR. REDDYS LAB WITH

MARKET STATS